Fulgent Genetics (FLGT) Other Operating Expenses (2015 - 2026)

Fulgent Genetics (FLGT) has 12 years of Other Operating Expenses data on file, last reported at -$24.5 million in Q1 2026.

• Quarterly Other Operating Expenses fell 79.09% year-over-year to -$24.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$5.2 million (up 12.87% YoY) and the FY2025 annual result came in at $49.9 million, up 12.87% from the prior year.
• Other Operating Expenses slipped to -$24.5 million in Q1 2026 per FLGT's latest filing, from $11.5 million in the prior quarter.
• The five-year high for Other Operating Expenses was $132.7 million in Q4 2023, with the low at -$24.5 million in Q1 2026.
• Average Other Operating Expenses over 5 years is $9.8 million, with a median of $10.6 million recorded in 2024.
• Year-over-year, Other Operating Expenses soared 656.78% in 2023 and tumbled 224.66% in 2025.
• Fulgent Genetics' Other Operating Expenses stood at -$23.8 million in 2022, then soared by 656.78% to $132.7 million in 2023, then slumped by 91.31% to $11.5 million in 2024, then decreased by 0.23% to $11.5 million in 2025, then plunged by 313.06% to -$24.5 million in 2026.
• Business Quant data shows FLGT's Other Operating Expenses at -$24.5 million in Q1 2026, $11.5 million in Q4 2025, and -$6.5 million in Q3 2025.